In today’s fast-paced digital landscape, businesses face a critical challenge: balancing efficiency with innovation. While off-the-shelf software once seemed convenient, companies increasingly realize ...

Generic secrets are hard to detect and are getting leaked more often. See how GitGuardian offers advanced protection where ...

The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic ...

Belgium’s record scorer Romelu Lukaku said he considered quitting the national side after last year’s disappointing European ...

Eli Lilly launches anti-obesity and diabetes drug Mounjaro in India, priced competitively at Rs 14,000-17,500, a fraction of ...

Eli Lilly launches diabetes and obesity drug Mounjaro in India, offering innovative treatment for metabolic health management ...

Sino Biopharm has a good financial position. As of December 2024, it has CNY 9.6 billion in cash on hand and CNY 9.6 billion in debt. Total debt outstanding is 14.7% of its total assets. Its capital ...

StockNews.com upgraded shares of Teva Pharmaceutical Industries (NYSE:TEVA – Free Report) from a hold rating to a buy rating ...

The tech-heavy Nasdaq Composite index recently entered correction territory. Though it was able to climb out of it, equities ...

Yet another suit alleges an ERISA fiduciary breach regarding the administration of a corporate healthcare plan.

Info-Tech Research Group, a global IT research and advisory firm, has announced the launch of its 5-Day IT Management ...

PCRX has put up a strong performance in six months with shares rallying 66.8%. However, its sole dependence on Exparel for growth is a concern. We advise investors to wait for now.